Healthcare Services

Digital Biomarkers Market: Emerging Trends Through 2030

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Digital Biomarkers Market Expected To Scale Between 2026 And 2030?

The digital biomarkers market has experienced significant expansion over recent years. Its valuation is anticipated to climb from $4.96 billion in 2025 to $6.26 billion in 2026, driven by a compound annual growth rate (CAGR) of 26.3%. This past growth can be attributed to several factors such as increased adoption of consumer wearables, the proliferation of mobile health applications, a rising incidence of chronic diseases, the presence of advanced biosensors, and a growing emphasis on preventive healthcare.

The digital biomarkers market is projected to experience substantial growth over the next few years. Its valuation is expected to reach $15.77 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 26.0%. This expansion during the forecast period is primarily fueled by increasing investments in digital health platforms, a rising demand for personalized healthcare monitoring, the broader application of predictive health analytics, growing integration with electronic health records, and enhanced regulatory support for digital biomarkers. Prominent trends throughout this period include the increasing adoption of wearable health monitoring devices, a rise in the use of continuous remote patient monitoring, expanding integration of AI-based health analytics, the proliferation of sensor-based disease tracking, and an intensified focus on real-time health data collection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

What Primary Drivers Are Shaping The Digital Biomarkers Market?

The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the digital biomarkers market. These are long-term health conditions that typically progress slowly and last for an extended period, often for life. The risk of developing chronic diseases is heightened by factors such as age-related conditions like osteoarthritis, Alzheimer’s disease, and heart disease, coupled with high consumption of processed foods and reduced physical activity. Digital biomarkers are employed in chronic diseases to monitor health metrics and disease progression in real time, enabling more personalized and timely interventions. For instance, in April 2025, the Centers for Disease Control and Prevention, a US-based federal public health agency, reported that 76.4% of US adults, representing about 194 million people, had one or more chronic conditions in 2023, with the prevalence being 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the higher prevalence of chronic diseases will propel the growth of the digital biomarker market.

What Are The Main Segments Within The Digital Biomarkers Market Segment Structure?

The digital biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

What Trends Are Affecting The Growth Of The Digital Biomarkers Market?

Leading companies in the digital biomarker market are increasingly employing a strategic partnership approach to broaden their market presence and enrich their service portfolios. Such a strategic partnership typically involves a cooperative arrangement between two or more entities, where they merge their resources, knowledge, and efforts to fulfill common objectives. For instance, in September 2023, ProofPilot, a US-based provider of clinical trial automation, entered into a strategic partnership with Eli Lilly and Company, a US-based pharmaceutical firm. The aim was to integrate Lilly’s innovative, patent-pending sensor cloud platform, Magnol.AI, into ProofPilot’s existing technology suite. Magnol.AI is an advanced platform meticulously designed for managing high-frequency sensor data with superior security and operational ease. This collaboration is intended to improve the execution of high-quality digital health research and expedite pre-competitive biomedical studies. The integration offers researchers the ability to utilize real-time data science functionalities and extract deep insights from sensor data, aligning with feedback from clinicians and patients to further digital health and biomarker investigations.

Who Are The Companies Participating In The Digital Biomarkers Market?

Major companies operating in the digital biomarkers market are Pfizer Inc, Bayer AG, F Hoffmann-La Roche Ltd, Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc, Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Ōura Health Oy., Evidation Health Inc, AliveCor Inc, Empatica Inc, ActiGraph LLC, VivoSense Inc, BioSensics LLC, Koneksa Health Inc, ATCOR Medical Pty Ltd, Brainomix Limited

Get The Full Digital Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Which Region Is The Largest In The Digital Biomarkers Market?

North America was the largest region in the digital biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Digital Biomarkers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Browse Through More Reports Similar to the Global Digital Biomarkers Market 2026, By The Business Research Company

Digital Payments Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-payments-global-market-report

Digital Publishing Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-publishing-global-market-report

Digital Pc Games Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-pc-games-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795